Canada markets closed

Q BioMed Inc. (QBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0006+0.0001 (+20.00%)
At close: 02:29PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-11-30
2021-11-30
2020-11-30
Total Revenue
209.293
284.352
195.597
30
Cost of Revenue
221.895
293.34
246.846
326.009
Gross Profit
-12.602
-8.988
-51.249
-296.009
Operating Expenses
Research Development
58.801
125.378
1,074
1,880
Selling General and Administrative
2,655
3,311
6,263
10,969
Total Operating Expenses
2,714
3,437
7,337
12,849
Operating Income or Loss
-2,726
-3,446
-7,389
-13,145
Interest Expense
1,247
1,384
506.922
296.215
Total Other Income/Expenses Net
-
2,778
-345.063
-50.562
Income Before Tax
-485.457
-2,052
-8,241
-13,492
Income from Continuing Operations
-485.457
-2,052
-8,241
-13,492
Net Income
-485.082
-2,052
-8,241
-13,492
Net Income available to common shareholders
-1,909
-3,494
-8,741
-14,350
Basic EPS
-0.33
-0.08
-0.33
-0.65
Diluted EPS
-0.33
-0.08
-0.33
-0.65
Basic Average Shares
26,779
44,757
26,779
22,160
Diluted Average Shares
26,779
44,757
26,779
22,160